Author:
Papp Kim,Prajapati Vimal H.,Maari Catherine,Legault Mark,Barakat Maxime,Vender Ronald
Reference5 articles.
1. Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ;Curmin;J Eur Acad Dermatol Venereol,2022
2. Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasis;Gooderham;J Dermatol,2022
3. Blockade of the IL-17R with AMG 827 leads to rapid reversal of gene expression and histopathologic abnormalities in human psoriatic skin;Russell;J Invest Dermatol,2010
4. Brodalumab to the rescue: efficacy and safety of brodalumab in patients with psoriasis and prior exposure or inadequate response to biologics;Menter;Dermatol Ther (Heidelb),2020
5. Long-term skin clearance with brodalumab in patients with psoriasis and inadequate response to prior biologics;Lebwohl;J Drugs Dermatol,2022